Skip to main content
Premium Trial:

Request an Annual Quote

Raafat Fahim, Robert Connelly, James Hussey, Lee Houghton, Kami Howard, Christopher Salentine, Fred Vitale, Jin He, Kyle Ingersoll, Anna VanAgtmael, Joseph Gess, Melissa Hayworth, Teresa Stanek Rea, Randolph Ross, Asaf Batelman, Mary Bram, Deborah Yellin,


Rockville, Md., Biopharmaceutical Promotes COO/GM to President/CEO
Raafat Fahim has been named president and CEO of Nabi Biopharmaceuticals, a Rockville, Md., developer of products that target gram-positive bacterial infections and nicotine addiction. Fahim — who also joins Nabi’s board of directors — succeeds Leslie Hudson, who had served as interim president and CEO since February 2007, and will remain on the board of directors.
Fahim was promoted from chief operating officer and general manager of Nabi’s biologics strategic business unit. He joined the company in March 2003 as vice president of vaccine manufacturing operations, and later that year was named senior vice president for research, technical, and manufacturing operations.
Before joining Nabi, Fahim spent most of his career with Sanofi-Pasteur and its predecessor company Aventis Pasteur, where he held positions of increasing importance in R&D, late development, and operations. He spent the last eight years there as vice president of industrial operations.
Fahim received his PhD in biochemistry from the University of Toronto.

Domantis Founder Named CEO of Respiratory Disease Therapeutics Company
Robert Connelly has joined Pulmatrix, a Lexington, Mass., respiratory disease therapeutics company, as CEO. He succeeds founding CEO Mark Gabrielson, who has formed p-Value Capital LLC, an investment firm specializing in the pharmaceutical industry; Gabrielson remains a director of the company.
Connelly was formerly the founding CEO of Domantis, a biotechnology company he founded in 2001. Connelly raised $73 million in private equity capital and grew Domantis into a 75-person organization before selling the company to GlaxoSmithKline in January 2007 for $454 million.
Previously, he spent 11 years with Abbott Laboratories and six years with IGEN International, now Bioveris.
Gabrielson co-founded Pulmatrix in 2003 with Harvard University professor David Edwards, and Massachusetts Institute of Technology professors Bob Langer and Alexander Klibanov.

Life Sciences Nano Manufacturer Taps Biopharmaceutical Senior Manager as New CEO
James Hussey has been appointed CEO and a director of NanoInk, a company specializing in nanometer-scale manufacturing and applications development for the life sciences and semiconductor industries. NanoInk is based at the Illinois Science + Technology Park in Skokie, Ill.
Hussey will remain involved with his previous employer Ovation Pharmaceuticals, a biopharmaceutical company in Deerfield, Ill., as a member of its external advisory board. Hussey previously served on Ovation’s senior management team. Earlier, Hussey served as president and CEO of NeoPharm, a biotech company specializing in R&D and marketing of cancer drugs.
As an angel investor, Hussey has been involved with or founded several early-stage biotechnology companies including Silamed Pharmaceuticals, ProCor Pharmaceuticals and Barbeau Pharmaceuticals. He currently serves on the Board of the Illinois Biotechnology Industry Organization.
Hussey began his career at Bristol-Myers Squibb, where he held positions in marketing, sales, and new business development before being appointed to general manager in 1994. A year later, he founded and served as CEO of Physicians Quality Care, a physician management services organization in Oak Brook, Ill. which was sold in 1998.
Hussey received his BSci degree in Pharmacy from Butler University and his MBA degree from the University of Illinois at Chicago.

Utah Healthcare Informatics Company Appoints New COO, CFO
Lee Houghton has been named senior vice president and chief operating officer, and Kami Howard, CFO of ZYTO, an Orem, Utah, healthcare informatics company that uses quantum science to enable communication between computers and the human body and mind.
Houghton was previously vice president of manufacturing and quality assurance, and joined ZYTO in the spring of 2007, after holding positions in the commercial real estate industry, and before that in the cabinet manufacturing industry for 16 years.
Howard joined ZYTO in April 2007 as COO, where she handled financial responsibilities, after spending five years at Browz as a vice president and corporate controller. Previously, she held a similar executive position with BioMeridian.

South San Francisco Biopharmaceutical Names New Manufacturing VP; Business Officer Departs
Christopher Salentine has been promoted to vice president of manufacturing by Hana Biosciences, a South San Francisco, Calif., biopharmaceutical company focused on cancer care.
Hana also announced, but gave no reason for, the departure of Fred Vitale, vice president and chief business officer.
Before joining Hana, Salentine was senior director of pharmaceutical manufacturing and development at Intarcia Therapeutics. Previously, he worked for Acologix as director of pre-clinical development. Salentine also spent six years as a project manager at Dow Pharmaceutical Sciences, where his duties included the management of new product development for prescription topical products.
Salentine received his PhD in chemistry from the University of California, Los Angeles, and his BSci with honors in chemistry from the University of California, Berkeley.

Scientist, Two Technologists, Join Grand Rapids, Mich., Research Center
The Center for Molecular Medicine in Grand Rapids, Mich., has increased its staff to eight people following its recent hiring of a scientist and two medical technologists:
  • Jin He, who previously served as a senior lab technician at the University of Kentucky's Department of Clinical Science, has been hired as a scientist. She received her bachelor's degree in clinical medicine from Anhui Medical University, located in China’s Anhui province. She received her master's in molecular and cell biology from the University of Kentucky.
  • Kyle Ingersoll previously served as a molecular technologist at Spectrum Health. Prior to Spectrum Health, he served as a research technician at Calvin College. Ingersoll began his career at Assay Design, where he served as an intern and junior scientist before being promoted to product support scientist. Ingersoll received his bachelor's degree in biotechnology from Ferris State University. He is a board-certified laboratory specialist in molecular biology.
  • Anna VanAgtmael previously worked as a medical technologist at Metro Health Hospital. In this role, she served as a generalist in the laboratory. VanAgtmael received a bachelor's degree in medical technology from Michigan State University and a bachelor's degree in clinical laboratory science from Grand Valley State University. While attending Michigan State, she also served as a laboratory technician. She too is a board-certified medical technologist.
CMM, a joint venture between Spectrum Health and Van Andel Institute, both based in Grand Rapids, focuses on investigation of complex diseases like cancer, heart disease, and mental illness, as well as other conditions at the DNA, RNA and protein levels.

Crowell & Moring Adds Seven Lawyers to Intellectual Property Group
The law firm Crowell & Moring has added seven patent lawyers to its intellectual property group, all formerly of the law firm Buchanan Ingersoll & Rooney. Crowell and Moring said the seven will increase the size of its intellectual property group to more than 55 attorneys, and expand its representation of clients within the chemical, pharmaceutical, and biotechnology industries.
Three of the seven have been named partners in the firm, and will be based at its Washington, DC, office:
  • Joseph Gess focuses on biotechnology, chemistry, litigation and trademarks. He previously headed Buchanan Ingersoll’s Alexandria, Va., and Silicon Valley offices, chaired the firm’s chemical practice group, and served on the firm’s board of directors. Gess obtained his law degree with honors from George Washington University National Law Center, and his undergraduate degree in chemistry from the University of Michigan.
  • Melissa Hayworth focuses on biochemistry, organic chemistry, pharmaceutical chemistry, polymer chemistry, and petroleum chemistry. She was a former corporate patent attorney at Roche Bioscience and 3M Innovative Properties and a research chemist at Burroughs Wellcome. Hayworth obtained her law degree from Duke University, and her undergraduate degree in chemistry from North Carolina State University.
  • Teresa Stanek Rea focuses on complex patent litigation and inter partes matters, as well as patent procurement and portfolio management, including patent preparation and prosecution. A former pharmacist and corporate patent attorney, Rea is the president-elect of the American Intellectual Property Law Association, set to take office in October. She previously served as co-chair of Buchanan Ingersoll’s intellectual property executive committee and chair of its biotechnology practice group. Rea obtained her law degree from Wayne State University and her undergraduate degree in pharmacy from University of Michigan.
Another lawyer has been named counsel:
  • Randolph Ross focuses on patent litigation and other commercial litigation. Ross, who will be resident in the New York office, obtained his law degree from Cornell Law School. He earned his MDiv from Yale University and his BA from the University of Virginia.
Three lawyers have been named associates:
  • Asaf Batelman, who is based at the Washington office, focuses his intellectual property practice on the preparation and prosecution of patent applications. Prior to practicing law, he was a cooperative education student at the Lubrizol Corporation and IBM Microelectronics Division. He received his JD degree from the University of North Carolina Law School in 2003, and graduated summa cum laude with his BSci degree in engineering from Case Western Reserve University.
  • Mary Bram and Deborah Yellin have also been named associates. Biographical information on both was unavailable.

Entrepreneur Named to Board of Connecticut Innovations
Peter Cashman, chairman of Cashman Computer Associates, an Old Lyme, Conn., computer technology solution provider,has been namedby Gov. Jodi Rellto the board of directors of Connecticut Innovations, the state’s quasi-public authority for technology investing and innovation development,based in Rocky Hill, Conn.
Cashman, a former Connecticut lieutenant governor, lives in Fairfield, Conn., and also manages a variety of private investment funds.
He previously served as chairman, CEO, and founder of Environmental Data Resources, a Milford, Conn., environmental risk information company whose investors included CI; and earlier was the chairman and CEO of the Sanborn Map Company, acquired by EDR in 1996.  While leading EDR, he was named Entrepreneur of the Year by the Information Industry Association. 
Cashman also previously was president and co-founder of BCA Environmental Services, a manufacturer of pollution control equipment and provider of environmental consulting and laboratory services; and executive vice president of York Research Corporation.
Cashman served as lieutenant governor under former Governor Thomas Meskill, and earlier had been a state senator and president pro-tem of the Connecticut State Senate. Cashman currently serves on CI’s Eli Whitney Advisory Committee, which evaluates and analyzes proposed investments, and previously served on the Clean Energy Advisory Committee, advising the CI board of directors on matters related to the Connecticut Clean Energy Fund.

Organism-Based Fatty Acid Maker Adds Food Ingredient/Biotech Executive to its Board
Robert Mayer has been elected to the board of directors of Martek Biosciences, a Columbia, Md.-based maker of fatty acids derives from algae, fungi, and other organisms, and used in foods, beverages, infant formula, and supplements.
From 1981 to 2007, Mayer held a variety of executive positions for Danisco, a global producer of ingredients for food and other consumer products. Most recently, he was CEO and chairman of Genencor International, a wholly-owned Danisco subsidiary focusing on the development and manufacture of industrial enzymes.
He continues to serve on the board of directors of Kalsec, a Kalamazoo, Mich.-based privately held food additive company.
Mayer holds a doctorate in chemical engineering from the Massachusetts Institute of Technology, and a BSci degree in chemical engineering from Columbia University.

Law Firm’s Managing Shareholder Named to Advisory Council of Valparaiso University
Jeff Harder, managing shareholder of law firm Winstead PC in the Woodlands, Tex., has joined the National Council for the College of Business Administration at Valparaiso University in Indiana, his alma mater. The council is an advisory body to the college’s dean, and consists of VU alumni who have demonstrated knowledge of the fundamentals of business success.

Harder joined Winstead to head up the firm's biotechnology industry group in April 2004. Previously, he served as in-house counsel for Mitchell Energy and Development Corp., the developer of the Woodlands master-planned mixed-use community. Harder began focusing on the biotech industry at MEDC while it developed the Research Forest life sciences campus, created to house companies capitalizing on technology transferred from the Medical Center in Houston. Earlier, he served as in-house counsel for Exxon and Amoco parent Standard Oil of Indiana.

Harder has spent more than 20 years advising venture capitalists, entrepreneurs and emerging biotechnology, life science, energy and information technology companies. He has been a frequent judge in the annual Rice University Business Plan competition, and serves on the advisory boards to the Houston Technology Center, BioHouston and the Rice Alliance.
Harder received his JD degree from the University of Illinois College of Law, where he graduated cum laude, and his BA degree from Valparaiso University with highest distinction.

Boulder, Colo., Early-Stage Consultancy Adds Senior Partner In Bay Area
Jerry Newman has been named a senior partner for Newman Venture Advisors, a Boulder, Colo., firm that provides advice and strategic consulting to early- and mid-stage startups. He will be based in the San Francisco Bay Area.
Newman most recently worked at Bears Stearns, where he managed the investment firm's venture capital coverage. Newman has also held positions at Hambrecht and Quist, Cowen and Company, JP Morgan, and Merrill Lynch.
The new position unites Newman with his son Ari Newman, who runs Newman Venture Advisors.

Texas Healthcare and Bioscience Institute Names Plano, Janek Legislators of the Year
Texas Rep. Brian McCall (R-Plano) and state Sen. Kyle Janek (R-Galveston)have been named Legislators of the Year by the Texas Healthcare and Bioscience Institute, which cited their creating tax incentives to businesses that create clean rooms, and other economic development efforts for the state’s biotechnology industry.

McCall is in his ninth term and represents a district that includes North Dallas, Frisco, Allen, and Plano. Janek is in his third term of representing parts of Harris, Fort Bend, Brazoria, Galveston, Chambers, and Jefferson counties in the state Senate.

The Texas Healthcare and Bioscience Institute is the statewide life science trade association in Texas. With a membership comprised of biotechnology, medical device, pharmaceutical and agricultural biotech companies, research entities, regional economic development entities, and other businesses providing goods and services to the life science industry, THBI advocates policies that will help grow the state’s life science industry

Maryland Taps Longtime Federal, Local Official as Director of International Trade and Investment
Robert Walker, a longtime official in the federal, Maryland state, and Anne Arundel County governments, has been appointed director of international trade and investment for the Maryland Department of Business and Economic Development.
Walker most recently served as chief administrative officer of Anne Arundel County from 2001 to 2006. Previously, he was a member of the US Department of Agriculture’s Foreign Agricultural Service from 1994 to 2001, and served as both secretary and deputy secretary of the Maryland Department of Agriculture from 1986 to 1994.
Walker has also regularly consulted with national and international organizations focused on policy, market and rural development, or food assistance in the nations of the former Soviet Union, Central Asia, and Africa.

Walker received his BA in political science from Towson University in 1970. He resides in Pasadena, Md.   

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.